RecruitingNCT06728891
Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy
Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy With D2 Lymphadenectomy Plus Complete Mesogastric Excision for Gastric Cancer: A Prospective Observational Study
Sponsor
Jichao Qin
Enrollment
100 participants
Start Date
May 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to evaluate the tumor deposit at the fusion site of the right gastric mesentery and left gastric mesentery in the patients with gastric cancer who received proximal gastrectomy.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria6
- Aged older than 18 years and younger than 85 years
- Primary gastric adenocarcinoma confirmed by preoperative pathology result
- cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition
- Patients undergoing proximal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision
- American Society of Anesthesiologists (ASA) class I, II, or III
- Written informed consent
Exclusion Criteria7
- Negative preoperative biopsy
- Too late tumour stage or metastasis (cT4b/M1)
- BMI\>30 kg/m2
- previous neoadjuvant chemotherapy or radiotherapy
- Previous upper abdominal surgery
- Combined with other malignant diseases
- Reject operation
Interventions
OTHERIn addition to routine diagnosis and treatment, no additional intervention measures were taken.
This study does not impose any intervention on the patients
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06728891
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
NCT068827463 locations
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401152 locations
Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer
NCT064082201 location
The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy
NCT071394181 location